Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anselm Pharmaceuticals is a private Indian pharmaceutical company based in Thane, Maharashtra, focused on commercialized branded generic medicines and distribution rather than novel drug R&D. Publicly available company listings and marketplace profiles indicate that it markets a portfolio spanning cardiovascular, antidiabetic, anti-infective, gastrointestinal, analgesic/anti-inflammatory, respiratory, and vitamin products. The company also advertises contract manufacturing services across dosage forms, including support for raw material procurement, production, packaging, and quality control. Available evidence suggests it operates as a small, private, active pharma business serving domestic commercial markets, with no clearly disclosed innovative biotech pipeline or clinical-stage assets. Its positioning appears closer to a pharma marketer/distributor and outsourcing-oriented supplier than to a discovery-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anselm Pharmaceuticals.